Cullinan oncology to participate in upcoming investor conferences

Cambridge, mass., feb. 27, 2024 (globe newswire) -- cullinan oncology, inc. (nasdaq: cgem) (“cullinan oncology”) a biopharmaceutical company focused on modality-agnostic targeted oncology therapies, today announced its participation in the following upcoming investor conferences:

CGEM Ratings Summary

CGEM Quant Ranking